Zurich Cantonal Bank’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,613
| Closed | -$11K | – | 2650 |
|
|
2024
Q3 | $11K | Sell |
10,613
-2,921
| -22% | -$4.01K | ﹤0.01% | 2611 |
|
|
2024
Q2 | $23.4K | Sell |
13,534
-1,988
| -13% | -$4K | ﹤0.01% | 2586 |
|
|
2024
Q1 | $37.1K | Sell |
15,522
-21,201
| -58% | -$52.2K | ﹤0.01% | 2594 |
|
|
2023
Q4 | $122K | Buy |
36,723
+10,238
| +39% | +$27.4K | ﹤0.01% | 2351 |
|
|
2023
Q3 | $99.1K | Sell |
26,485
-2,107
| -7% | -$9.73K | ﹤0.01% | 2355 |
|
|
2023
Q2 | $122K | Buy |
28,592
+45
| +0.2% | +$266 | ﹤0.01% | 2245 |
|
|
2023
Q1 | $195K | Sell |
28,547
-1,651
| -5% | -$12.8K | ﹤0.01% | 1874 |
|
|
2022
Q4 | $239K | Sell |
30,198
-358
| -1% | -$2.75K | ﹤0.01% | 1724 |
|
|
2022
Q3 | $294K | Sell |
30,556
-1,279
| -4% | -$12.9K | ﹤0.01% | 1524 |
|
|
2022
Q2 | $230K | Sell |
31,835
-1,430
| -4% | -$12.4K | ﹤0.01% | 1705 |
|
|
2022
Q1 | $429K | Buy |
33,265
+1,069
| +3% | +$13.6K | ﹤0.01% | 1429 |
|
|
2021
Q4 | $514K | Buy |
32,196
+189
| +0.6% | +$3.31K | ﹤0.01% | 1426 |
|
|
2021
Q3 | $514K | Sell |
32,007
-544
| -2% | -$7.97K | ﹤0.01% | 1276 |
|
|
2021
Q2 | $450K | Buy |
32,551
+1,174
| +4% | +$16.6K | ﹤0.01% | 1287 |
|
|
2021
Q1 | $458K | Buy |
31,377
+22,067
| +237% | +$375K | ﹤0.01% | 1286 |
|
|
2020
Q4 | $162K | Hold |
9,310
| – | – | ﹤0.01% | 1963 |
|
|
2020
Q3 | $171K | Hold |
9,310
| – | – | ﹤0.01% | 1718 |
|
|
2020
Q2 | $166K | Buy |
9,310
+4,693
| +102% | +$79.4K | ﹤0.01% | 1633 |
|
|
2020
Q1 | $75K | Buy |
4,617
+990
| +27% | +$18.3K | ﹤0.01% | 1757 |
|
|
2019
Q4 | $65K | Hold |
3,627
| – | – | ﹤0.01% | 1990 |
|
|
2019
Q3 | $73K | Hold |
3,627
| – | – | ﹤0.01% | 1782 |
|
|
2019
Q2 | $80K | Hold |
3,627
| – | – | ﹤0.01% | 1748 |
|
|
2019
Q1 | $49K | Buy |
3,627
+326
| +10% | +$4.35K | ﹤0.01% | 2016 |
|
|
2018
Q4 | $30K | Hold |
3,301
| – | – | ﹤0.01% | 2294 |
|
|
2018
Q3 | $54K | Buy |
3,301
+456
| +16% | +$8.08K | ﹤0.01% | 2106 |
|
|
2018
Q2 | $40K | Buy |
2,845
+2,244
| +373% | +$32.1K | ﹤0.01% | 2246 |
|
|
2018
Q1 | $7K | Hold |
601
| – | – | ﹤0.01% | 2515 |
|
|
2017
Q4 | $5K | Hold |
601
| – | – | ﹤0.01% | 2532 |
|
|
2017
Q3 | $8K | Hold |
601
| – | – | ﹤0.01% | 2449 |
|
|
2017
Q2 | $9K | Hold |
601
| – | – | ﹤0.01% | 2437 |
|
|
2017
Q1 | $13K | Hold |
601
| – | – | ﹤0.01% | 2425 |
|
|
2016
Q4 | $17K | Hold |
601
| – | – | ﹤0.01% | 2313 |
|
|
2016
Q3 | $16K | Buy |
601
+199
| +50% | +$5.43K | ﹤0.01% | 2297 |
|
|
2016
Q2 | $7K | Hold |
402
| – | – | ﹤0.01% | 2448 |
|
|
2016
Q1 | $9K | Hold |
402
| – | – | ﹤0.01% | 2381 |
|
|
2015
Q4 | $9K | Hold |
402
| – | – | ﹤0.01% | 2417 |
|
|
2015
Q3 | $8K | Buy |
+402
| New | +$12.2K | ﹤0.01% | 2196 |
|
Other funds holding CHRS
RCMNY
TCM
KKRC
CM
Zurich Cantonal Bank's CHRS Position: Q4 2024 in Review
Zurich Cantonal Bank sold out of Coherus Oncology (CHRS) in Q4 2024, closing a stake of 10,613 shares — an estimated $11K sold.
Zurich Cantonal Bank first reported a position in CHRS in Q3 2015 and held it in 37 quarters. The position peaked at $514K in Q4 2021. 124 funds tracked by Wall St. Rank hold CHRS as of Q4 2024.
- Zurich Cantonal Bank reported no remaining Coherus Oncology position as of Q4 2024 after selling out during the quarter.
- Zurich Cantonal Bank sold 10,613 Coherus Oncology shares in Q4 2024, an estimated $11K.
- Zurich Cantonal Bank first reported a position in Coherus Oncology in Q3 2015 and held it in 37 quarters.
- Zurich Cantonal Bank's Coherus Oncology position peaked at $514K in Q4 2021.
- 124 funds tracked by Wall St. Rank held Coherus Oncology as of Q4 2024.
Based on Zurich Cantonal Bank's 13F filing for Q4 2024, filed 7 Feb 2025.